Most observational studies used propensity-score matching (PSM) or within-individual designs to assess alcohol-related outcomes in patients treated with GLP1-RAs, often in populations with co-morbid T2DM or obesity. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.